SCHEMBL5366320

SCHEMBL5366320

CCOC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(NC(=O)CCC4CCCNC4)cc32)c1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 8/20 0.54
▸ PDGFRB P09619 6/20 0.54
▸ FGFR1 P11362 3/20 0.54
▸ ALK Q9UM73 2/20 0.54
▸ ABL1 P00519 1/20 0.54
▸ RET P07949 1/20 0.54
▸ CSF1R P07333 4/20 0.51
▸ MET P08581 2/20 0.47
▸ AURKB Q96GD4 2/20 0.47
▸ AURKA O14965 1/20 0.47
▸ AURKC Q9UQB9 1/20 0.47
▸ AKT2 P31751 1/20 0.46
▸ HDAC3 O15379 2/20 0.45
▸ HDAC4 P56524 2/20 0.45
▸ HDAC1 Q13547 2/20 0.45
▸ HDAC7 Q8WUI4 2/20 0.45
▸ HDAC2 Q92769 2/20 0.45
▸ HDAC10 Q969S8 2/20 0.45
▸ HDAC11 Q96DB2 2/20 0.45
▸ HDAC8 Q9BY41 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5369667 0.83 HDAC3 (0.65) FLT3PDGFRBFGFR1ALKABL1
SCHEMBL5359118 0.80 FLT3 (0.68) FLT3PDGFRBFGFR1ALKABL1
SCHEMBL5365979 0.79 FLT3 (0.66) FLT3PDGFRBFGFR1ALKABL1
SCHEMBL5357950 0.79 PAK1 (0.46) PDGFRBHDAC3HDAC4HDAC1HDAC7
SCHEMBL5362266 0.78 HDAC3 (0.46) PDGFRBHDAC3HDAC4HDAC1HDAC7
SCHEMBL5363278 0.77 PDGFRB (0.68) FLT3PDGFRBFGFR1ALKABL1
SCHEMBL5373331 0.77 TLK2 (0.67) FLT3PDGFRBAURKBAURKAAURKC
SCHEMBL5384496 0.77 FLT3 (0.62) FLT3PDGFRBFGFR1ALKABL1
SCHEMBL19255670 0.76 PDGFRB (0.77) FLT3PDGFRBFGFR1ALKABL1
SCHEMBL5373629 0.75 PDGFRB (0.76) FLT3PDGFRBFGFR1ALKABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 — — US disclosed
EP-1247803-A2 Indolinone compounds suitable for modulation of protein kinases Sugen, Inc. (US) 2002-10-09 — — EP disclosed
Send feedback